Upgrade to SI Premium - Free Trial

Veru, Inc. (VERU)

0.64 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/9/24)

Latest Headlines

Form 8-K VERU INC. For: Feb 21 February 28, 2024 6:06 AM - SEC Filing Veru (VERU) Receives Nasdaq Non-compliance Notice February 27, 2024 8:33 PM - StreetInsider Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q February 27, 2024 7:15 PM - Globe NewsWire Veru Announces New Scientific Advisory Board for its Enobosarm Program for High Quality Weight Loss February 20, 2024 8:30 AM - Globe NewsWire Veru, Inc. (VERU) Announces Delayed 10-Q Filing February 15, 2024 4:54 PM - StreetInsider Form NT 10-Q VERU INC. For: Dec 31 February 15, 2024 4:50 PM - SEC Filing Form 8-K VERU INC. For: Feb 15 February 15, 2024 4:07 PM - SEC Filing Form SC 13G/A VERU INC. Filed by: PERCEPTIVE ADVISORS LLC February 14, 2024 4:32 PM - SEC Filing Form 8-K VERU INC. For: Feb 08 February 8, 2024 7:01 AM - SEC Filing Veru Reports Fiscal 2024 First Quarter Financial Highlights February 8, 2024 6:30 AM - Globe NewsWire Form SC 13G/A VERU INC. Filed by: FROST PHILLIP MD ET AL February 6, 2024 4:28 PM - SEC Filing Veru (VERU) Announces FDA Clearance of IND Application to Initiate Phase 2b Trial of Enobosarm February 6, 2024 8:30 AM - StreetInsider Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs February 6, 2024 8:30 AM - Globe NewsWire Veru to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference January 31, 2024 8:30 AM - Globe NewsWire Form 8-K VERU INC. For: Jan 25 January 26, 2024 4:06 PM - SEC Filing Form DEFA14A VERU INC. January 26, 2024 9:03 AM - SEC Filing Form DEF 14A VERU INC. For: Mar 26 January 26, 2024 9:01 AM - SEC Filing Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024 January 25, 2024 8:31 AM - Globe NewsWire Veru, Inc. (VERU) Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss January 8, 2024 8:33 AM - StreetInsider Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss January 8, 2024 8:30 AM - Globe NewsWire Form SC 13G VERU INC. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C. December 26, 2023 4:31 PM - SEC Filing Veru to Host Investor Call on January 4th, 2024 to Discuss Recent Financing and Strategy to Prioritize the Development of Enobosarm as a Combination Treatment to Prevent Muscle Loss and Augment Fat Lo December 19, 2023 8:30 AM - Globe NewsWire Form 8-K VERU INC. For: Dec 14 December 18, 2023 9:01 AM - SEC Filing Form 424B5 VERU INC. December 15, 2023 4:04 PM - SEC Filing Veru (VERU) Prices 45.83M Share Offering at $0.72/sh December 14, 2023 9:01 AM - StreetInsider Veru Announces Pricing of Public Offering of Common Stock December 14, 2023 9:00 AM - Globe NewsWire Form 424B5 VERU INC. December 13, 2023 4:23 PM - SEC Filing Form 424B5 VERU INC. December 13, 2023 4:07 PM - SEC Filing Form 8-K VERU INC. For: Dec 13 December 13, 2023 4:04 PM - SEC Filing Veru, Inc. (VERU) Announces Proposed Public Offering of Common Stock December 13, 2023 4:01 PM - StreetInsider Veru Announces Proposed Public Offering of Common Stock December 13, 2023 4:01 PM - Globe NewsWire Form SC 13G/A VERU INC. Filed by: MORGAN STANLEY December 8, 2023 4:03 PM - SEC Filing Form 10-K VERU INC. For: Sep 30 December 8, 2023 2:31 PM - SEC Filing Full Article List